CLASSIFICATION OF DEFECTS PHARMACOTHERAPY AS THE BASIS OF QUALITY ASSESSMENT OF DRUG THERAPY IN HEALTHCARE
https://doi.org/10.20538/1682-0363-2013-3-82-91
Abstract
Optimization of pharmacotherapy, as improving the quality of care is an important goal of modern medicine. The solution to this problem can be realized with the development and adoption of clear formal criteria. Using aprocess-based approach, we have developed a method for detecting defects in pharmacotherapy. We have analyzed the prospects of using this approach to research the quality of pharmacotherapy in health care and the formation of national programs to improve the quality of care.
About the Authors
R. Kh. Khafisianova
Kazan State Medical University, Kazan
Russian Federation
Khafisianova Rofiya Kh.
Russian Federation
Khafisianova Rofiya Kh.
I. M. Burykin
Kazan State Medical University, Kazan
Russian Federation
Burykin Igor M.
Russian Federation
Burykin Igor M.
G. N. Aleeva
STADA Pharm Development Ltd., Moscow
Russian Federation
Aleeva Guzel N.
Russian Federation
Aleeva Guzel N.
References
1. Abramov A.Yu., Kolchu I.G., Kulakov A.A. et al. Bulletin Roszdravnadzora, 2011, no. 5, pp. 56–57 (in Russian).
2. Abrosimova N.V., Sulejmanov S.Sh., Kirpichnikova N.V. et al. Problem standardization in public health, 2010, no. 7–8, pp. 63–67 (in Russian).
3. Bedoreva I.Yu., Sadovaya T.N., Strygin A.V. et al. Spine Surgery, 2007, no. 4, pp. 62–72 (in Russian).
4. Burykin I.M., Aleeva G.N., Khafisianova R.KH. Assessment of the quality of pharmacotherapy with statins in patients with cardiovascular diseases at the stage of rehabilitation. Proceedings Russian conference «Actual issues to improve the quality of postgraduate training of pharmaceutical personnel», Kazan, 2012, vol. 1, pp. 10–13 (in Russian).
5. Burykin I.M., Aleeva G.N., Khafisianova R.Kh. The development of new approaches for evaluating quality in patient care based on standards. Proceedings Russian conference
6. «Actual issues to improve the quality of postgraduate training of pharmaceutical personnel», Kazan, 2011, pp. 20–23 (in Russian).
7. Vengerovsky A.I. Pharmacology. IV edition. Moskow, Geotar-Media Publ., 2012. 736 p. (in Russian).
8. Gadzhiev R.S., Agalarova L.S., Rahimov G.G. General practitioner, 2012, vol. 14, No. 3. pp. 27–30 (in Russian).
9. D'yachenko V.G. Examination of the quality of care (theory and practice), Habarovsk, Agency for international Development ENI/HR/HP, 1996. 183 p. (in Russian).
10. Eliseeva Ye.V. Drug safety and pharmacovigilance, 2008, no. 2, pp. 12–19 (in Russian).
11. Kazakevich D.V., Vdovichenko V.P. Prescription, 2010, no. 6, pp. 21–29 (in Russian).
12. Kondurceva V.A. Kupaev V.P., Mishheshso O.V. et al. Therapeutic archive, 2008, vol. 80, No. 1. pp. 20–23 (in Russian).
13. Koshevaya E.G. Health Far East, 2009, vol. 42, No. 4, pp. 44–47 (in Russian).
14. Murzova T.V., Senina-Volzhskaja I.V. Basic research, 2012, no. 7, pp. 224–229 (in Russian).
15. On approval of the medical criteria for determining the severity of harm to human health. Order The Ministry healthcare and Social Development Russian Federation, April 24 2008, no. 194n.
16. Paykov V.L., Ishmetov R.P. Kazan Medical Journal, 2012, vol. 93, no. 4, pp. 680–682 (in Russian).
17. Posnenkova O., Kiselev A., Gridnev V. et al. Cardiovascular therapy and prevention, 2012, vol. 11, no. 3, pp. 4–11 (in Russian).
18. The Order of the Federal Mandatory Medical Insurance Fund of the Russian Federation from 01.12.2010 N 230 "On approval of the organization and control of the volume, timing, quality and conditions of the provision of medical care for compulsory health insurance" (in Russian).
19. Ryzhova O.A., Moroz T.L. Siberian Journal of Medicine (Irkutsk), 2010, vol. 97, no. 6, pp. 201–203 (in Russian).
20. Sarkisian B.A., Shapkina N.B., Novoselov V.P. Siberian Journal of Medicine (Tomsk), 2010, vol. 25, no. 4–1, pp. 137–141 (in Russian).
21. Sergeev Yu.D., Kozlov S.V. Medical law, 2012, vol. 43, no. 3, pp. 35–38 (in Russian).
22. Suchkov A.V. Medical law, 2010, no. 5. pp. 45–50 (in Russian).
23. Suchkova T.E. Medical Law, 2011, no. 6., pp. 33–40 (in Russian).
24. Federal Law of the Russian Federation of 21.11.2011 N 323FZ "The basis of health protection in the Russian Federation" (in Russian).
25. Federal Law of the Russian Federation of 29.11.2010 N 326FZ "About obligatory Medical Insurance in the Russian Federation" (in Russian).
26. Fletcher R.H., Fletcher S.W., Wagner E.H. Clinical Epidemiology: The Essentials, Moscow, Media Sphera Publ., 1998, 352 p. (in Russian).
27. Khafisianova R.Kh., Burykin I.M., Aleeva G.N. Mathematical Statistics in Experimental and Clinical Pharmacology, Kazan, Medicine Publ., 2006, 374 p. (in Russian).
28. Khafisianova R.Kh., Burykin I.M., Aleeva G.N. Assessment of the quality of pharmacotherapy of angiotensin converting enzyme inhibitors in patients with cardiovascular disease using indicators. Proceedings of the X International Conference "Medical and social ecology of personality: Status and Prospects". Minsk, 2012. pp. 464–466 (in Russian).
29. Khafisianova R.Kh., Burykin I.M., Aleeva G.N. Bulletin of St. Petersburg University. Series 11, 2011, no.4. pp. 103–112 (In Russian).
30. Khafisianova R.Kh., Burykin I.M., Aleeva G.N. Knowledge management as a factor in the competitiveness of of health facilities in the current market conditions.International scientific – practical conference "The role of non-governmental organizations in addressing the problems associated with the development and introduction of innovative technologies in all spheres of human activity," dedicated to the 15th anniversary of the founding of the Academy of Informatization of the Republic of Tatarstan (part 1). Kazan, 2009, pp. 388–393.
31. Shalnova S.A., Konradi A.O., Karpov Yu.A. et al. Russ. J. Cardiol., 2012, vol. 97, no.5, pp. 6–11 (in Russian).
32. American College of Medical Quality. Medical quality management: theory and practice. Sudbury, Mass.: Jones and Bartlett Publishers, 2010.
33. Arnold C. Decreasing antibiotic overuse in neonatal intensive care units: quality improvement research. Proceedings (Baylor University. Medical Center), 2005, vol. 18, no. 3, pp. 280.
34. Donabedian A. The quality of medical care. Science, 1978. vol. 200, no. 4344. pp. 856–864.
35. Gleason K.M., Groszek J.M., Sullivan C. et al. Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients. Am. J. Health. Syst. Pharm., 2004. vol. 61, no. 16, pp. 1689–1695.IOM. Using Clinical Practice Guidelines to Evaluate Quality of Care: Issues & Methods. DIANE Publishing, 1995.
36. Laurence D.R., Bennet P.N. Clinical pharmacology. [S.l.]; New York: Englisch Language Book Society; Churchill Livingstone, 1987.
37. Mayer G.A. Training and Experience of Physicians in the Management of Adequate Anticoagulant Therapy. Can. Med. Assoc. J., 1965, vol. 92, no. 4, pp. 182–184.
38. McCarthy R. The price you pay for the drug not taken. Bus Health., 1998, vol. 16, no. 10, pp. 27–28, 30, 32–33.
39. McNulty C.A.M., Francis N.A. Optimizing antibiotic prescribing in primary care settings in the UK: findings of a BSAC multi-disciplinary workshop 2009. Journal of Antimicrobial Chemotherapy, 2010, vol. 65, no. 11, pp. 2278–2284.
40. Meyer-Massetti C., Conen D. Assessment, frequency, causes, and prevention of medication errors – a critical analysis. Ther Umsch., 2012, vol. 69, no. 6, pp. 347–352.
41. Schoenbaum S., Sundwall D., Bergman D. Using Clinical Practice Guidelines to Evaluate Quality of Care: Issues (vol. 1). Rockville, MD: Agency for Health Care Policy and Research Publication 95: 0045, 1995.
42. Spath P. Introduction to healthcare quality management. Chicago, Ill.; Washington, DC: Health Administration Press; AUPHA Press, 2009.
43. WHO. Introduction to drug utilization research. Oslo, Norway. 2003. 43 p.
Review
For citations:
Khafisianova R.Kh., Burykin I.M., Aleeva G.N. CLASSIFICATION OF DEFECTS PHARMACOTHERAPY AS THE BASIS OF QUALITY ASSESSMENT OF DRUG THERAPY IN HEALTHCARE. Bulletin of Siberian Medicine. 2013;12(3):82-91. (In Russ.) https://doi.org/10.20538/1682-0363-2013-3-82-91
Views:
853
Email this article 